Fragmin
Active substance: dalteparin
INJECTION · DALTEPARIN SODIUM 2500 [iU]/.2mL
United StatesActive
Marketing holder: Pfizer Laboratories Div Pfizer Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- DALTEPARIN SODIUM · 2500 [iU]/.2mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 12 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3579-7c16-b396-b9ffec7134ec,01a120c3-4c6e-7ede-b79c-bfe3a48bf705,01a120c3-5232-7a3a-885c-c79c70dfd666,01a120c3-5645-7c54-87e5-7717a349af83,01a120c3-854c-700e-b819-503ea938b2f8;count=11 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-31c2-7d53-bbdd-4adcb6b35d80,01a1208f-337c-7597-b296-971ca3572f01,01a12092-ee4f-7795-9afa-8b257af3d5e1,01a12095-35a1-7161-9981-877ee18d73f9,01a12097-7f44-7cdc-aa84-913c11c84699;count=9 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 0069-0195
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
- product · openFDA NDC · 0069-0195 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0069-0195 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0069-0195 · Verified 2026-10-09 · open in source